Advertisement

Related Videos

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Amit Sanyal, MD: A Clinician’s Perspective

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Advertisement

Advertisement




Sep
30
Today In Oncology
Cleveland Clinic to Host Second Annual AI Summit for Health-Care Professionals
Cleveland Clinic President Discusses AI Summit for Health-Care Professionals
AI’s Evolving Role in Clinical Care Enterprise-Wide
Long-Term Disease Control From SBRT Equal to Surgery in Localized Prostate Cancer
Cancer Statistics 2026: What Every Medical Oncologist Should Know
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo